Live news related to BIOMERIEUX stock (FR0013280286): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The stock of the Lyon-based in vitro diagnostics specialist is regaining some ground this Thursday after a dismal week. Having recorded a new seven-ye…
The stock of the Lyon-based in vitro diagnostics specialist continues its downward spiral. In mid-afternoon on Wednesday, April 29, 2026, the stock fe…
BioMérieux's stock price has increased by 2.4% at the start of the week, reaching 72.65 euros during the session, after closing last Friday at 70.95 e…
Shares of the in vitro diagnostics specialist plummeted to 71.45 euros this Friday, down 2.46% from the previous day. The drop follows the announcemen…
On this Thursday, BioMérieux's stock experienced a sharp drop on Euronext Paris, falling nearly 17% to €73.75. The Lyon-based in vitro diagnostics com…
The in vitro diagnostics group bioMérieux has revised its annual targets downward following a first quarter impacted by weak respiratory epidemiology …
bioMérieux's stock closed the Thursday session on April 9 at €89.60, down 3.29% from the previous day. This decline highlights a marked downward traje…
The in vitro diagnostics specialist's stock fell close to 2% this Tuesday, amidst a generally declining Parisian market. This new session of decline a…
bioMérieux has announced the acquisition of the CE mark under the IVDR directive for two diagnostic tests for respiratory and pharyngeal infections. T…
BioMérieux's stock experienced a significant decline of 2.75% this Thursday, March 5, closing at 95.40 euros after ending at 98.10 euros the previous …
